Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-25 @ 1:17 AM
NCT ID:
NCT02495493
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed gastric cancer
* Clinical stage : - Borrmann type IV
* Large Borrmann type III (\>8cm)
* Locally extensive nodal disease
* No evidence of metastasis
* Patients with tumor lesions which can be easily obtained fresh tumor tissue through repeated biopsies.
* At least one measurable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 criteria.
* Age≥ 20 years old.
* Performance status of Eastern Cooperative Oncology Group 0 to 2.
* Adequate organ function.
Exclusion Criteria:
1. metastatic disease
2. Other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ.
3. Subjects with an uncontrolled major cardiovascular disease (including AMI within 12 months, unstable angina within 6 months, over NYHA class III congestive heart failure, congenital long QT syndrome, 2° or more AV Block and uncontrolled hypertension)
4. Pregnant or lactating female
5. Evidence of any other significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02495493
Study Brief:
Protocol Section:
NCT02495493